Key Takeaways Intel stands to benefit from higher tax credits under the new law signed on July 4. Boosted funding supports INTC's IDM 2.0 plan and U.S. expansion in Arizona, Ohio, Oregon and New Mexico. INTC is mulling to shift focus to 14A production to strengthen its foundry position and streamline operations.With tax credits for semiconductor firms rising to 35% from the existing 25% slab, the new tax bill (dubbed as the ‘One Big Beautiful Bill’) that President Trump signed into law on July 4 has seemi ...

The Zacks Computer-Peripheral Equipment industry players like LG Display (LPL) , Immersion (IMMR) and TransAct Technologies (TACT) are well-poised to benefit from the growing demand for professional gaming accessories, touchscreen and wireless devices, smart glasses and RFID (Radio Frequency Identification) solutions. A continuously improving shipment of personal computers (PCs) bodes well for PC peripheral market prospects. Moreover, the solid demand for 3D-printed health equipment like face shields, nasal ...

Affirm Holdings (AFRM) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Over the past month, shares of this operator of digital commerce platform have returned +16.1%, compared to the Zacks S&P 500 composite's +3.9% change. During this period, the Zacks Internet - Software industry, which Affirm Holdings falls in, has gained 2.7%. The key question now is: What could be the stock's futur ...

Oportun Financial Corporation (OPRT) shares soared 8.6% in the last trading session to close at $7.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 0.7% gain over the past four weeks.Oportun extended its gains for the third consecutive session, climbing higher yesterday after the company issued a letter to shareholders reaffirming its support for CEO Raul Vazquez. In the letter, Oportun urged investors to vote in favor of reta ...

Allot Communications (ALLT) shares ended the last trading session 8% higher at $9.21. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 4.6% loss over the past four weeks.The sharp rise in the stock price was fueled by optimistic investor sentiment, sparked by recent analyst upgrades, promising earnings potential, an expanding customer base, and the effective rollout of the company’s security solutions.This internet ...

Medicus Pharma Ltd. Announces Submission of Type C Meeting Request to the Food and Drug Administration (FDA)The Company's aim is to seek FDA consent to fast track the Clinical Development Program to treat Basal Cell Carcinoma (BCC) of the skin using Dissolvable Doxorubicin-containing Microneedle Arrays (D-MNA)July 08, 2025 7:30 AM EDT | Source: Medicus Pharma Ltd.Philadelphia, Pennsylvania--(Newsfile Corp. - July 8, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is ple ...

Seasoned Leader Brings Deep Experience in Oncology Drug Development as Company Advances Portfolio of Next Generation Therapeutics for Solid Tumors WALTHAM, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced the appointment of Jan Pinkas, Ph.D., as chief scientific officer. Dr. Pinkas brings more than two decades of experience in o ...

Montreal, Quebec, Canada, July 08, 2025 (GLOBE NEWSWIRE) -- Canada Carbon Inc. (TSX-V: CCB), (“Canada Carbon” or “the Company”) announces that it has obtained all necessary permits from the Quebec government to commence with its third drilling campaign in three years at the Asbury Graphite Property (”Asbury”), located near the municipality of Notre-Dame-du-Laus in the province of Quebec. As Figure 1 shows below, the Company intends to complete a drilling campaign which will provide up to 5,200 meters of cor ...

CAIRO, July 8, 2025 /PRNewswire/ -- To enhance the quality of life for its residents, Tatweer Misr, one of Egypt's leading real estate developers, has selected Otis (NYSE: OTIS), the world's leading elevator and escalator manufacturing, installation and service company, to supply and install smart vertical mobility solutions across its urban communities. Tatweer Misr's current engagement with Otis represents six projects and 1,250 elevators over six years. From left to right: Dr. Ahmed Shalaby, Co-Found ...

业绩总结 - Tebipenem HBr在复杂尿路感染(cUTI)的III期临床试验中已停止，因在预先指定的中期分析中显示出疗效[3] - Tebipenem HBr在1,690名患者的临床试验中达到了主要终点，且未发现新的安全性问题[18] - Tebipenem HBr在10项试验中共招募了超过950名受试者，显示出良好的耐受性[25] 用户数据 - 每年约有290万次cUTI治疗事件，导致美国医疗费用超过60亿美元[16] - 公司在日本自2009年以来已批准Tebipenem Pivoxil，至今已有超过400万患者接受治疗[26] 未来展望 - Tebipenem HBr的全球商业合作伙伴关系与GSK具有强大的经济效益，预计将在2025年下半年提交美国监管申请[3][4] - 公司预计将继续开发SPR720，并完成其IIa期数据分析以确定下一步计划[4] 新产品和新技术研发 - Tebipenem HBr的全球知识产权保护有效期至2041年，且获得了快速审评药物(QIDP)的资格[18] - Tebipenem在2022年对来自欧洲和美国的临床重要耐药肠杆菌尿路感染病原体表现出活性，样本总数为2,447，最小抑菌浓度（MIC）为0.12 µg/mL[28] - Tebipenem的口服生物利用度约为60%，在进食或空腹状态下均表现出剂量依赖的药代动力学关系[29] 市场扩张和并购 - Spero与GSK签署独家许可协议，获得6600万美元的预付款和900万美元的普通股投资，此外还有高达4亿美元的潜在监管、商业和销售里程碑付款[32] - Spero在与FDA达成SPA协议后获得3000万美元，预计在2025年下半年收到2375万美元的开发里程碑付款[33] - Tebipenem HBr的NDA提交后，Spero将获得2500万美元的付款，基于首次商业销售的潜在商业里程碑高达1.5亿美元[33] 负面信息 - SPR720的临床试验显示出抗微生物活性，但中期分析未能显示出与安慰剂的显著差异，且在1000 mg的剂量下存在潜在的安全性问题[37]